SCHEMBL6906879

SCHEMBL6906879

O=C(CCc1ccc(Cl)cc1)c1cc(O)ccc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.58
CHRNA7 P36544 1/20 0.56
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
MAPT P10636 4/20 0.51
CYP3A4 P08684 2/20 0.51
HPGD P15428 2/20 0.51
MAPK1 P28482 2/20 0.51
KDM4E B2RXH2 1/20 0.51
SLC16A3 O15427 1/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
TTR P02766 1/20 0.51
ESR1 P03372 1/20 0.51
TP53 P04637 1/20 0.51
CYP1A2 P05177 1/20 0.51
POLB P06746 1/20 0.51
GAA P10253 1/20 0.51
CYP2D6 P10635 1/20 0.51
THRB P10828 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9748707 0.84 CYP19A1 (0.66) CYP19A1CHRNA7MEN1KMT2AMAPT
SCHEMBL10830275 0.81 MEN1 (0.67) CYP19A1MEN1KMT2AMAPTCYP3A4
SCHEMBL10988386 0.81 CYP19A1 (0.76) CYP19A1MEN1KMT2AMAPTHPGD
SCHEMBL330648 0.80 NFKB1 (0.59) MEN1KMT2AMAPTLMNAPOLB
SCHEMBL10830031 0.79 MEN1 (0.54) CYP19A1MEN1KMT2AMAPTHPGD
SCHEMBL454232 0.78 SLC5A1 (0.78) CYP19A1MEN1KMT2AMAPTCYP3A4
Davidigenin SCHEMBL30291870 0.77 CYP19A1 (0.70) CYP19A1MEN1KMT2AMAPTCYP3A4
SCHEMBL11431321 0.77 NPC1 (0.69) CYP19A1MEN1KMT2AMAPTCYP3A4
SCHEMBL7187280 0.77 CHRNA7 (0.71) CYP19A1CHRNA7MAPTCYP3A4HPGD
Davidigenin SCHEMBL750182 0.77 CYP19A1 (0.70) CYP19A1MEN1KMT2AMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040176471-A1 Novel chalcone derivatives and pharmaceutical compositions comprising the same KAOHSIUNG MEDICAL UNIVERSITY 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176471-A1 Novel chalcone derivatives and pharmaceutical compositions comprising the same PTGS1, PTGES2, PTGES CYP19A1 103/4885CHRNA7 3981/4885MEN1 4271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.